TANDEM DIABETES CARE INC. overview

TNDM DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM PR Newswire NEW YORK, Nov. 7, 2023 NEW YORK , Nov. 7, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 and November 2, 2022 , both dates inclusive (the "Class Period"), of the...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM PR Newswire NEW YORK, Nov. 3, 2023 NEW YORK , Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Tandem and certain of its...

TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit PR Newswire LOS ANGELES, Nov. 3, 2023 LOS ANGELES , Nov. 3, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM ). Class Period: August 3, 2022 – November 2, 2022 Lead Plaintiff Deadline: November 7, 2023 If...

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc.(TNDM) Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire NEW YORK, Nov. 2, 2023 NEW YORK , Nov. 2, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Tandem investors who were adversely affected by alleged securities...

TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit PR Newswire BENSALEM, Pa., Oct. 31, 2023 BENSALEM, Pa. , Oct. 31, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM ). Class Period: August 3, 2022 – November 2, 2022 Lead Plaintiff Deadline: November 7, 2023...

LOS ANGELES, CA / ACCESSWIRE / October 31, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ:TNDM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 3, 2022 and November 2, 2022,...

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Tandem Diabetes Care, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2023 - (NASDAQ: TNDM) PR Newswire NEW YORK, Oct. 31, 2023 NEW YORK , Oct. 31, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Tandem Diabetes Care, Inc.. Shareholders who purchased shares of TNDM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff...

TNDM NOTICE: NATIONALLY RANKED ROSEN LAW FIRM Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM PR Newswire NEW YORK, Oct. 30, 2023 NEW YORK , Oct. 30, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 and November 2, 2022 , both dates inclusive (the "Class Period"), of the important...